Northside Hospital Orthopedics has become the first provider in Georgia to use a new surgical procedure for treating knee osteoarthritis. Last month, Dr. Timilehin Wusu performed the MISHA (Medial Implantable Shock Absorber for the Knee) system surgery. The MISHA device is approved by the U.S. Food and Drug Administration to address medial compartment knee osteoarthritis.
Produced by Moximed Inc., the implant is designed to reduce knee pain and improve function in patients with this condition. Dr. Wusu said, “I’ve had patients complain to me for years that there’s got to be something that can be done to help reverse their arthritis.” He added, “These were always active, young-at-heart people that didn’t want to give up their active lifestyle and weren’t ready to concede to a total knee (replacement). With the MISHA, I finally have something to offer them. It doesn’t reverse the arthritis, but it does effectively reverse their knee pain, while allowing them to be as active as they want to be.
“And even better, it preserves their sense of youthful vigor.”
Osteoarthritis occurs when cartilage cushioning the bones at a joint wears down over time, leading to pain and swelling during movement. According to available data, about 18 million Americans experience symptomatic knee osteoarthritis; more than half are of working age. Many adults with mild or moderate symptoms face limited treatment options if conservative care fails and they are not eligible or willing candidates for total knee replacement surgery.
The MISHA implant reduces peak forces on the knee by more than 30% with each step and does not require bone cutting during implantation. The procedure also preserves the natural cartilage surfaces of the joint.
Dr. Wusu performed this surgery at Northside Hospital Duluth on a 54-year-old woman.
Learn more about orthopedic care at Northside.
